These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3415422)

  • 1. Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Results of a two-year controlled study.
    Hogarty GE; McEvoy JP; Munetz M; DiBarry AL; Bartone P; Cather R; Cooley SJ; Ulrich RF; Carter M; Madonia MJ
    Arch Gen Psychiatry; 1988 Sep; 45(9):797-805. PubMed ID: 3415422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate.
    Marder SR; Aravagiri M; Wirshing WC; Wirshing DA; Lebell M; Mintz J
    Schizophr Res; 2002 Jan; 53(1-2):25-30. PubMed ID: 11728835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very high dose fluphenazine decanoate: a controlled trial in chronic schizophrenia.
    McClelland HA; Farquharson RG; Leyburn P; Furness JA; Schiff AA
    Arch Gen Psychiatry; 1976 Dec; 33(12):1435-9. PubMed ID: 11760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
    Inderbitzin LB; Lewine RR; Scheller-Gilkey G; Swofford CD; Egan GJ; Gloersen BA; Vidanagama BP; Waternaux C
    Am J Psychiatry; 1994 Dec; 151(12):1753-9. PubMed ID: 7977881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.
    Schooler NR; Keith SJ; Severe JB; Matthews SM; Bellack AS; Glick ID; Hargreaves WA; Kane JM; Ninan PT; Frances A; Jacobs M; Lieberman JA; Mance R; Simpson GM; Woerner MG
    Arch Gen Psychiatry; 1997 May; 54(5):453-63. PubMed ID: 9152099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and benefits of two doses of fluphenazine.
    Marder SR; Van Putten T; Mintz J; McKenzie J; Lebell M; Faltico G; May PR
    Arch Gen Psychiatry; 1984 Nov; 41(11):1025-9. PubMed ID: 6437365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome.
    Marder SR; Van Putten T; Mintz J; Lebell M; McKenzie J; May PR
    Arch Gen Psychiatry; 1987 Jun; 44(6):518-21. PubMed ID: 3555385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates.
    Kane JM; Rifkin A; Woerner M; Reardon G; Sarantakos S; Schiebel D; Ramos-Lorenzi J
    Arch Gen Psychiatry; 1983 Aug; 40(8):893-6. PubMed ID: 6347119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expressed emotion, fixed-dose fluphenazine decanoate maintenance, and relapse in recent-onset schizophrenia.
    Nuechterlein KH; Snyder KS; Dawson ME; Rappe S; Gitlin M; Fogelson D
    Psychopharmacol Bull; 1986; 22(3):633-9. PubMed ID: 3797570
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks.
    Carpenter WT; Buchanan RW; Kirkpatrick B; Lann HD; Breier AF; Summerfelt AT
    Am J Psychiatry; 1999 Mar; 156(3):412-8. PubMed ID: 10080557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.
    Marder SR; Midha KK; Van Putten T; Aravagiri M; Hawes EM; Hubbard JW; McKay G; Mintz J
    Br J Psychiatry; 1991 May; 158():658-65. PubMed ID: 1860020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug-response differences of high and standard dosage of fluphenazine-decanoate in relation to schizophrenic symptoms (author's transl)].
    Lehmann E; Quadbeck H; Tegeler J; Fararuni M; Heinrich K
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):117-29. PubMed ID: 7393998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluphenazine decanoate: a clinical problem?
    Inderbitzin LB; Lewine RR; Gloersen BA; Rosen PB; McDonald SC; Vidanagama BP
    Am J Psychiatry; 1989 Jan; 146(1):88-91. PubMed ID: 2563210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of relapse in schizophrenia. An evaluation of fluphenazine decanoate.
    Schooler NR; Levine J; Severe JB; Brauzer B; DiMascio A; Klerman GL; Tuason VB
    Arch Gen Psychiatry; 1980 Jan; 37(1):16-24. PubMed ID: 7352836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia.
    Marder SR; Wirshing WC; Van Putten T; Mintz J; McKenzie J; Johnston-Cronk K; Lebell M; Liberman RP
    Arch Gen Psychiatry; 1994 Apr; 51(4):280-7. PubMed ID: 8161288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotion.
    Hogarty GE; Anderson CM; Reiss DJ; Kornblith SJ; Greenwald DP; Javna CD; Madonia MJ
    Arch Gen Psychiatry; 1986 Jul; 43(7):633-42. PubMed ID: 2872870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of low and conventional doses of fluphenazine on schizophrenic outpatients with good or poor information-processing abilities.
    Asarnow RF; Marder SR; Mintz J; Van Putten T; Zimmerman KE
    Arch Gen Psychiatry; 1988 Sep; 45(9):822-6. PubMed ID: 3046554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose fluphenazine decanoate in maintenance treatment of schizophrenia.
    Kane JM; Rifkin A; Quitkin F; Nayak D; Saraf K; Ramos-Lorenzi JR; Klein DF; Sachar EJ
    Psychiatry Res; 1979 Dec; 1(3):341-8. PubMed ID: 233160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial].
    Woggon B; Dick P; Fleischhauer HJ; Gmür M; Gruber G; Angst J; Heimann H
    Int Pharmacopsychiatry; 1977; 12(4):193-209. PubMed ID: 22515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.